<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Isocaloric Diets High in Animal or Plant Protein Reduce Liver fat and Inflammation in Individuals with Type 2 Diabetes</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Mariya</forename><surname>Markova</surname></persName>
							<email>mariya.markova@dife.de.</email>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Olga</forename><surname>Pivovarova</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Silke</forename><surname>Hornemann</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephanie</forename><surname>Sucher</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Turid</forename><surname>Frahnow</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katrin</forename><surname>Wegner</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Institute of Food Chemistry</orgName>
								<orgName type="department" key="dep2">School of Food Science</orgName>
								<orgName type="institution">University of Hamburg</orgName>
								<address>
									<settlement>Hamburg, Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jürgen</forename><surname>Machann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Institute of Diabetes Research and Metabolic Diseases</orgName>
								<orgName type="institution">Helmholtz Center Munich at the University of Tuebingen</orgName>
								<address>
									<settlement>Tuebingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Diagnostic and Interventional Radiology</orgName>
								<orgName type="laboratory">Section on Experimental Radiology</orgName>
								<orgName type="institution">University Hospital Tuebingen</orgName>
								<address>
									<settlement>Tuebingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jürgen</forename><surname>Klaus</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Johannes</forename><surname>Petzke</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ralf</forename><surname>Hierholzer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Lichtinghagen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Maren</forename><surname>Herder</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Carstensen-Kirberg</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Natalia</forename><surname>Roden</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susanne</forename><surname>Rudovich</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ralph</forename><surname>Klaus</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rosemarie</forename><surname>Thomann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sascha</forename><surname>Schneeweiss</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">F H</forename><surname>Rohn</surname></persName>
						</author>
						<author>
							<persName><surname>Pfeiffer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Klaus</forename><forename type="middle">Jürgen</forename><surname>Petzke</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johannes</forename><surname>Hierholzer</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Diagnostic and Interventional Radiology</orgName>
								<orgName type="institution">Ernst von Bergmann Hospital</orgName>
								<address>
									<settlement>Potsdam</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ralf</forename><surname>Lichtinghagen</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute of Clinical Chemistry</orgName>
								<orgName type="institution">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Herder</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Institute for Clinical Diabetology</orgName>
								<orgName type="department" key="dep2">German Diabetes Center</orgName>
								<address>
									<settlement>Duesseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maren</forename><surname>Carstensen-Kirberg</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Institute for Clinical Diabetology</orgName>
								<orgName type="department" key="dep2">German Diabetes Center</orgName>
								<address>
									<settlement>Duesseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Roden</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Institute for Clinical Diabetology</orgName>
								<orgName type="department" key="dep2">German Diabetes Center</orgName>
								<address>
									<settlement>Duesseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Endocrinology and Diabetology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Heinrich Heine University Duesseldorf</orgName>
								<address>
									<settlement>Duesseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Natalia</forename><surname>Rudovich</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susanne</forename><surname>Klaus</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ralph</forename><surname>Thomann</surname></persName>
							<affiliation key="aff10">
								<orgName type="institution">Institut für Getreideverarbeitung GmbH</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rosemarie</forename><surname>Schneeweiss</surname></persName>
							<affiliation key="aff11">
								<orgName type="institution">Institute for Food and Environmental Research</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sascha</forename><surname>Rohn</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Institute of Food Chemistry</orgName>
								<orgName type="department" key="dep2">School of Food Science</orgName>
								<orgName type="institution">University of Hamburg</orgName>
								<address>
									<settlement>Hamburg, Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Institute for Food and Environmental Research</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">F H</forename><surname>Pfeiffer</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<addrLine>Arthur-Scheunert-Allee 114-116</addrLine>
									<postCode>14558</postCode>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Isocaloric Diets High in Animal or Plant Protein Reduce Liver fat and Inflammation in Individuals with Type 2 Diabetes</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">7D1B0051297349C67425E21306F345EA</idno>
					<idno type="DOI">10.1053/j.gastro.2016.10.007</idno>
					<note type="submission">Gastroenterology Accepted Date: 9 October 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:47+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The funding source had no role in study design, data collection, analysis or interpretation, report writing, or the decision to submit this paper for publication.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The ectopic accumulation of excessive fat in the liver, non-alcoholic fatty liver disease (NAFLD) is closely linked to obesity and insulin resistance and may progress to non-alcoholic steatohepatitis (NASH) which provides a high risk of progression to advanced liver diseases.</s><s>Incidence of NAFLD is rapidly increasing in industrialized countries and is associated with cardiovascular disease and type 2 diabetes (T2D). <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> </s><s>iver fat content is highly depending on nutritional intake and energy metabolism.</s></p><p><s>Hypercaloric Western style diets with high content of animal protein, carbohydrates, and saturated fats promote liver fat accumulation. <ref type="bibr" target="#b2">3</ref></s><s>Carbohydrates are known to induce lipogenesis by activating the carbohydrate responsive transcription factor carbohydrate response element binding protein (ChREBP). <ref type="bibr" target="#b3">4</ref></s><s>Hepatic lipogenesis additionally requires the activation of mammalian target of rapamycin complex 1 (mTORC1) to induce sterol regulatory element-binding transcription factor 1c (SREBP1c). <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6</ref> </s><s>ranched chain amino acids (BCAA) recruit mTOR and assemble mTORC1 in cooperation with insulin and thereby support tissue hypertrophy and proliferation, inhibit autophagy and proteolysis and impair insulin sensitivity. <ref type="bibr" target="#b6">7</ref></s><s>The mTOR substrate p70S6 kinase was shown to induce insulin resistance in muscle upon activation by infusion of amino acids in humans. <ref type="bibr" target="#b7">8</ref></s><s>Thus, activation of mTORC1 by high intake of protein would be expected to deteriorate metabolic control and to increase hepatic triglycerides.</s><s>However, high-protein diets have shown variable <ref type="bibr" target="#b8">9</ref> and sometimes even favorable effects on glucose metabolism and insulin sensitivity in people with T2D <ref type="bibr" target="#b9">10</ref> and it is unclear which metabolic pathways are involved. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">11</ref> </s><s>emarkably, diets restricted in methionine were shown to prevent the development of insulin resistance and of the metabolic syndrome in animal models by activating the protective fibroblast growth factor 21 (FGF21) pathway. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13</ref> </s><s>oreover, BCAA were proposed to induce insulin resistance by clogging mitochondrial ATP-production. <ref type="bibr" target="#b13">14</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><note type="other">9</note><p><s>Therefore, the type of protein may elicit different metabolic responses depending on the amino acid composition.</s><s>Notably, plant proteins contain much lower levels of methionine and BCAA than proteins of animal origin, which was proposed to mediate some advantages of vegetarian diets. <ref type="bibr" target="#b14">15</ref></s><s>It is therefore hypothesized that high plant-protein diets exert favorable effects on hepatic fat content and metabolic responses as compared to high intake of animal protein rich in BCAA and methionine.</s></p><p><s>The metabolic hormone FGF21 was shown to be elevated in, and to predict, fatty liver disease in humans. <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17</ref> </s><s>reatment with FGF21, however, ameliorated fatty liver disease by modifying lipogenic pathways and fat oxidation in animal models. <ref type="bibr" target="#b17">18</ref></s><s>Remarkably, fructose and sugar intake acutely increased circulating FGF21 in humans and mice <ref type="bibr" target="#b18">19</ref> being partly mediated by ChREBP. <ref type="bibr" target="#b19">20</ref></s><s>Another potent stimulus elevating FGF21 is protein deficiency, which acts via the stress induced transcription factor ATF4. <ref type="bibr" target="#b11">12</ref> A moderate increase of free fatty acids (FFA) increased FGF21 in humans involving peroxisome proliferator-activated receptor alpha (PPARα) associated signaling, as well. <ref type="bibr" target="#b20">21</ref></s><s>Thus, FGF21 is strongly regulated by macronutrient intakes in humans which is closely related to liver fat content.</s><s>It is further hypothesized that changes of FGF21 might be involved in the effects of protein enriched diets on liver fat and should be particularly effective in plant diets with low content of methionine.</s></p><p><s>3]<ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref> In lean and healthy individuals, high protein blunted the increase of intrahepatic lipids (IHL) induced by fructose <ref type="bibr" target="#b21">22</ref> or high fat diet. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25</ref> </s><s>n 11 obese women, IHL decreased by 20% after whey supplementation for 4 weeks, only 5 subjects however, exhibited IHL over 5%. <ref type="bibr" target="#b22">23</ref></s><s>High-protein interventions in patients with NAFLD are lacking.</s><s>Moreover, there is no data whether the origin of dietary protein plays a role in liver fat accumulation in humans with NAFLD or not.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants and study design</head><p><s>In this 6-week intervention study 44 individuals with T2D were assigned by group matching for age, sex, BMI, HbA 1c and glucose lowering drugs using random number generator either to a group consuming an animal protein (AP) or plant protein (PP) rich diet.</s><s>A total of 37 subjects (n AP =18, n PP =19) aged between 49-78 years completed the study.</s><s>Both diets were isocaloric and had the same macronutrient composition (30 E% protein, 40 E% carbohydrates, 30 E% fat).</s><s>Macronutrient intake of individuals prior to enrollment was 17 E% protein, 42 E% carbohydrates, 41 E% fat.</s><s>The animal-protein diet (AP) was rich in meat and dairy foods, the plant-protein diet (PP) consisted mainly of legume protein (see Supplementary Material for detailed information).</s><s>On the clinical investigation days (CID) at beginning and end of interventions, hyperinsulinemic euglycemic clamps and meal tolerance tests (MTT) were performed; blood, urine and subcutaneous adipose tissue (SAT) samples were collected (see Supplementary Material).</s><s>Individuals had glycated hemoglobin A 1c (HbA 1c ) levels of 5.8-8.8% at recruitment.</s><s>None of the patients had impaired renal (glomerular filtration rate &lt; 60 ml/min/1.73</s><s>m²), liver, or thyroid function;</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>12 none had glucocorticoid therapy, stroke or heart attack in the last 6 months, or cancer in the last 2 years; and none had acute or chronic inflammatory disease, mental disorders and depression, food intolerance and weight change greater than 3 kg within the previous 3 months.</s><s>Participants were asked to maintain their physical activity patterns for the duration of the study.</s><s>At each visit they arrived in a fasted state.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Body composition, magnetic resonance imaging (MRI) and spectroscopy ( 1 H-MRS)</head><p><s>Body composition was determined by Air Displacement Plethysmography (BOD POD®, COSMED, Italy).</s><s>MRI and 1 H-MRS were performed on a 1.5 T whole body scanner (Magnetom Avanto, Siemens Healthcare, Germany) for quantification of abdominal fat depots and intrahepatic lipids, respectively <ref type="bibr" target="#b25">26</ref> (see Supplementary Material for detailed description).</s><s>Indirect calorimetry (Vmax® Encore metabolic cart, CareFusion, Yorba Linda, USA) was performed in the fasting state to estimate the resting energy expenditure and the respiratory quotient.</s><s>The substrate oxidation was calculated according following equations: carbohydrate oxidation [g/min] = 4.55 x V CO2 − 3.21 x V O2 ; fat oxidation [g/min] = 1.67 x V O2 − 1.67 x V CO2 .</s><s>Protein oxidation was estimated from the urinary urea nitrogen excretion from 24-h urine. <ref type="bibr" target="#b26">27</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Biomarkers in serum and plasma</head><p><s>Fasting blood was collected at week 0 and 6 of the intervention.</s><s>Routine markers were measured in serum using ABX Pentra 400 (Horiba, Japan).</s><s>Biomarkers in serum samples were measured by ELISA: Insulin (Mercodia, Sweden), IL-18, MCP-1, adiponectin, and FGF21 (R&amp;D Systems, USA), caspase-cleaved Keratin 18 fragment by M30-Apoptosense ELISA (Peviva, Sweden); IL-8 and TNFα using Luminex magnetic bead technology (Luminex Performance Human High Sensitivity Cytokine Magnetic Panel, R&amp;D Systems, USA); IL-6 using sandwich immunoassays (MSD, USA).</s><s>Fasting</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>13 plasma levels of FFA were determined by gas chromatography (GC), analysis of free amino acids (FAA) was performed using LC-MS, and the levels of amino-terminal propeptide of type III procollagen (PIIINP) and enhanced liver fibrosis (ELF) score on ADVIA Centaur CP immunochemical analyzer according to manufacturer's instructions (Siemens Healthcare Diagnostics, Germany).</s><s>Index of whole-body insulin resistance (HOMA-IR) was calculated as: fasting insulin [µU/ml] x fasting glucose in [mM] / 22.5; index of adipose tissue insulin resistance (AdipoIR) as:</s></p><p><s>fasting insulin [µU/ml] x fasting total FFA [µg/ml].</s><s>Detailed description of protein and gene analysis in adipose tissue is provided in Supplementary Material.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>The study enrolled 44 subjects, and 7 of them dropped out.</s><s>The results are expressed as mean ± SEM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline characteristics of the participants</head><p><s>A total of 37 participants concluded the clinical study (animal-protein group (AP): 6 females, 12 males; plant-protein group (PP): 7 females, 12 males).</s><s>Subjects were 65.0 ± 1.4 (AP) and 63.7 ± 1.5 (PP) years old, moderately obese with BMI of 31.0 ± 0.8 (AP) and 29.4 ± 1.0 (PP).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Intrahepatic lipids and anthropometry</head><p><s>Content of intrahepatic fat was determined at baseline and after 6 weeks of intervention by 1 H-MRS.</s><s>A highly significant reduction of IHL in both groups, by 48.0% and 35.7% in AP and PP, respectively was observed (P AP =0.0002, P PP =0.001) (Figure <ref type="figure" target="#fig_9">1A</ref>).</s><s>Moreover, in 9 subjects (n AP =3, n PP =6) IHL levels fell below 5.56% und thus below the threshold defining NAFLD. <ref type="bibr" target="#b27">28</ref></s><s>Liver enzymes in serum decreased during the intervention in both groups, particularly γ-GT and AST, without significant differences between groups.</s><s>Additionally, the AST/ALT ratio was below 1 in both groups and not influenced by the diets.</s><s>Keratin 18 fragment, a marker of necro-apoptotic processes in liver, <ref type="bibr" target="#b28">29</ref> declined significantly in all participants (P=0.002), and significantly in the PP but not AP subgroup (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Levels of PIIINP and ELF score were within the reference intervals <ref type="bibr" target="#b29">30</ref> and no changes were observed in either of the groups (Table <ref type="table" target="#tab_0">1</ref>).</s><s>However, there was a trend to improvement of the ELF score (P=0.071) in 5 subjects with a score above 9.8 at baseline who were likely to display some degree of fibrosis. <ref type="bibr" target="#b29">30</ref></s><s>tably, the relative decrease of liver fat correlated with the relative reductions of fasting glucose (Figure <ref type="figure" target="#fig_4">2A</ref>) and fasting insulin (Figure <ref type="figure" target="#fig_4">2B</ref>).</s><s>Despite consumption of an isocaloric diet and the attempt to keep body weight constant by increasing food intake, participants in both groups showed a moderate but significant reduction of BMI (AP: -0.8 kg/m 2 ± 0.1 kg; PP: -0.5 ± 0.1 kg/m 2 ), which was not significantly different between the groups (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Fat mass decreased and fat-free mass detected by whole-body plethysmography increased in both groups with minor differences.</s><s>Visceral (VAT) and</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>15 non-visceral (NVAT) adipose tissue contents measured by MRI were reduced in both groups being highly significant in the AP group (VAT: -9.7%, P&lt;0.001; NVAT: -7.4%, P&lt;0.0001) (Figure <ref type="figure" target="#fig_9">1B</ref>).</s><s>Furthermore, hip circumference decreased in both groups, as well as the adipose tissue content, measured at the level of the femoral head (AT femur ) (Table <ref type="table" target="#tab_0">1</ref>).</s><s>None of the changes of body fat correlated with changes of IHL (data not shown).</s><s>Noteworthy, whole-body insulin sensitivity, expressed as M-value, improved in both groups and correlated significantly with reductions of IHL (Figure <ref type="figure" target="#fig_4">2C</ref>).</s></p><p><s>Resting energy expenditure (REE) and respiratory quotient did not change during the intervention.</s><s>As expected, protein oxidation, calculated from the urinary urea nitrogen excretion, increased significantly in all participants without differences between groups (Table <ref type="table" target="#tab_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FFA and FAA blood levels</head><p><s>In the fasting state FFA in the circulation are largely derived from SAT lipolysis <ref type="bibr" target="#b30">31</ref> and provide an index of insulin sensitivity and processes occurring in adipose tissue.</s><s>To assess changes of lipid metabolism in adipose tissue upon the high-protein diet and its possible contribution to the IHL reduction, FFA levels before and after the intervention were measured.</s><s>A significant decrease of all saturated FFA (SFA) from C14:0 to C24:0 and of monounsaturated FFAs (MUFA) was observed in both groups with the exception of odd-chain fatty acid levels (Table <ref type="table" target="#tab_1">2</ref>).</s><s>With regard to polyunsaturated fatty acids (PUFA), levels of linoleic acid (C18:2n6) did not change while arachidonic acid (C20:4n6) decreased significantly in both groups.</s><s>Remarkably, the levels of γ-linolenic acid (C18:3n6) decreased, while levels of α-linolenic acid (C18:3n3) increased in both groups with the changes being more pronounced in the AP group.</s><s>This was accompanied by a significant decrease of the AdipoIR index in both groups (Table <ref type="table" target="#tab_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>16 Furthermore, the index of de novo lipogenesis (DNL index = 16:0/18:2n6) decreased significantly in both groups and a significant decrease of the elongase activity index (C18:0/C16:0), but no change of the stearoyl-CoA desaturase-1 (SCD1) index (C16:1n7/C16:0) was observed.</s><s>Importantly, ∆5 desaturase activity index (C20:4n6/C20:3n6) decreased significantly in PP, while ∆6 desaturase activity decreased (C18:3n6/C18:2n6) in AP group (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Collectively, these results show a very specific pattern of changes regarding preserved ω-6 FFA which were associated with reduced diabetes risk. <ref type="bibr" target="#b31">32</ref></s><s> expected, at baseline we observed a significant correlation of circulating free fatty acids with IHL.</s></p><p><s>Strong correlations were observed for saturated FFA including C14:0, C16:0 and C18:0 as well as for palmitoleic acid (C16:1n7) with IHL (Supplementary Figure <ref type="figure" target="#fig_9">1A</ref>).</s><s>These correlations remained significant after intervention (Supplementary Figure <ref type="figure" target="#fig_9">1B</ref>).</s><s>The reduction of γ-linoleic acid (Figure <ref type="figure" target="#fig_4">2E</ref>) and the reduction of the DNL index correlated with the change in IHL (Figure <ref type="figure" target="#fig_4">2F</ref>).</s></p><p><s>To investigate whether alterations of circulating amino acids contributed to IHL reduction, fasting plasma FAA levels before and after intervention were measured.</s><s>Analysis showed no significant changes in the levels of 14 amino acids.</s><s>Only taurine decreased in both groups (Supplementary Figure <ref type="figure" target="#fig_4">2</ref>).</s><s>Interestingly, changes of plasma asparagine correlated with the reduction of IHL in the PP group (r= -0.568, P=0.027).</s></p><p><s>As amino acids are rapidly taken up by the cells, postprandial levels of FAA after a test meal with the typical composition of the AP and PP diets were also determined.</s><s>BCAA (leucine, isoleucine, and valine) and methionine contents were higher after the AP meal in comparison to the PP meal, while arginine and asparagine were higher after the PP meal in comparison to the AP meal (Supplementary Table <ref type="table" target="#tab_0">1</ref>).</s><s>The PP group showed larger increases of asparagine and arginine (Figure <ref type="figure" target="#fig_5">3A-B</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FGF21</head><p><s>FGF21 correlates with anthropometric indices in humans including liver fat as we could confirm in our cohort (Supplementary Table <ref type="table" target="#tab_1">2</ref>), and the increase was proposed to reflect ER-stress in human NAFLD. <ref type="bibr" target="#b32">33</ref></s><s>FGF21 might therefore play a role in the protein induced reduction of liver fat.</s></p><p><s>Unexpectedly, FGF21 levels were reduced by 42.6% and 51.1% in the AP and PP groups, respectively (P AP &lt;0.0002, P PP &lt;0.0002) (Figure <ref type="figure" target="#fig_9">1C</ref>).</s><s>There was also a positive association between the reduction of FGF21 and IHL in the entire cohort (r=0.363,</s><s>P=0.049).</s></p><p><s>FGF21 stimulates the release of adiponectin and requires adiponectin to reduce liver fat and improve insulin sensitivity in mice. <ref type="bibr" target="#b33">34</ref></s><s>Indeed, a modest reduction of circulating adiponectin which was most pronounced in the PP group (Table <ref type="table" target="#tab_0">1</ref>) and a correlation with FGF21 after the intervention was observed (Supplementary Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inflammatory markers</head><p><s>The metabolic syndrome and NAFLD are linked to subclinical inflammation. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b2">3</ref> </s><s>herefore, changes of important inflammatory cytokines were assessed.</s><s>IL-4, IL-6, IL-8 and MCP-1 did not change during the intervention, while the inflammasome processed cytokine IL-18 decreased in the AP group, and TNFα decreased in the PP group (Supplementary Figure <ref type="figure" target="#fig_5">3</ref>).</s><s>This indicated a modest reduction of inflammatory markers with the high-protein diets.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gene expression and protein modification in adipose tissue</head><p><s>In view of the extensive changes in lipid metabolism and of FGF21 associated with IHL reduction upon high-protein diet, we further investigated its molecular mechanisms using available SAT samples</s></p><formula xml:id="formula_0">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 18</formula><p><s>collected before and after the intervention (n AP =12, n PP =15).</s><s>We analyzed diet-induced changes of signaling pathways in SAT and measured expression of genes playing a key role in de novo lipogenesis, lipid storage, lipolysis and lipid uptake, as well as main enzymes in BCAA metabolism, ER-stress and FGF21 pathways using real-time PCR (Figure <ref type="figure" target="#fig_6">4</ref>).</s><s>Overall, the gene expression of lipolytic and lipogenic enzymes was decreased which was significant for ACC1, involved in de novo lipogenesis, in the AP group (Figure <ref type="figure" target="#fig_6">4A</ref>).</s><s>Furthermore, expressions of enzymes of lipid storage were decreased in both groups (PGC1A and PPARG in PP, SCD1 in AP).</s><s>Expression of the lipolytic enzyme HSL and ADIPOQ were also lower in the PP group (Figure <ref type="figure" target="#fig_6">4A</ref>).</s><s>ER-stress related genes remained unchanged (Figure <ref type="figure" target="#fig_6">4B</ref>).</s><s>FGFR1 expression was significantly reduced in the PP group (Figure <ref type="figure" target="#fig_6">4C</ref>).</s></p><p><s>We further tested the hypothesis that high intake of BCAA from animal-protein rich diet activates the mTOR pathway in humans.</s><s>The expression of the main enzymes in BCAA-metabolism, BCAT2 and BCKDH, was unchanged in adipose tissue of either group (Figure <ref type="figure" target="#fig_6">4D</ref>).</s><s>In addition, we measured the mRNA expression and phosphorylation state of enzymes in the Akt-mTOR pathway in SAT.</s><s>No differences were observed in gene expression of kinases in the Akt-mTOR pathway (AKT, MTOR, P70S6K, 4EBP1) (Figure <ref type="figure" target="#fig_7">5A</ref>).</s><s>Furthermore, the phosphorylation state of several key enzymes of this pathway (assessed in a subgroup: n AP =8, n PP =8) did not change, except for a significant decrease of the phosphorylation of p70S6K (Thr421/Ser424) in the AP group (Figure <ref type="figure" target="#fig_7">5B</ref>).</s></p><p><s>Although expression of particular genes was significant only in one of dietary groups studied, similar trends were found in both groups, and there were no statistical differences between groups.</s><s>We then used a bioinformatics approach to understand the interaction of pathways involved and calculated correlation networks.</s><s>The changes of gene expression showed high correlations of β-Klotho (KLB) with the major lipid metabolic enzymes FASN, ACC1, SCD1, ATGL, HSL, but also PPARG and</s></p><formula xml:id="formula_1">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 19</formula><p><s>SREBP1c indicating a critical role of the FGF21 pathway (Figure <ref type="figure" target="#fig_6">4E</ref>).</s><s>Remarkably MTOR and its pathway including P70S6K, 4EBP1, as well as components of autophagy ATG5 and LC3A/B were highly correlated confirming their central regulatory role in human metabolic adaptation to high-protein diet (Figure <ref type="figure" target="#fig_6">4E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 20</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The most important finding of our study is that provision of a 6-week high-protein diet that did not restrict caloric intake, very effectively reduced IHL by 36 -48% in subjects with T2D and NAFLD.</s><s>This strategy was accompanied by an improvement of metabolic and inflammatory parameters and therefore provides a powerful and safe treatment approach.</s><s>The loss of liver fat was highly related to changes of lipid metabolism as shown by the decreases of saturated and other FFA and indices of lipogenesis.</s><s>Despite the elevated intake and postprandial uptake of methionine and BCAA in the AP group, there was no indication of negative effects of these components.</s><s>The origin of protein -animal or plant -did not play a major role.</s><s>Both high-protein diets unexpectedly induced strong reductions of FGF21 which was associated with metabolic improvements and the decrease of IHL.</s></p><p><s>Hepatic fat is regulated by a complex array of metabolic phenomena which reflect metabolic balance in numerous organs. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b34">35</ref> </s><s>mbalance between lipid supply (de novo lipogenesis and FFA flux) and lipid disposal (VLDL secretion and lipid oxidation) leads to increased fat accumulation in liver.</s><s>In the post-absorptive state fatty acid uptake by the liver is directly related to the concentration of FFA in the circulation. <ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b35">36</ref> </s><s>AFLD is associated with insulin resistance of adipose tissue and increased rates of lipolysis, <ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b37">38</ref> which increase further depends on the extent of obesity. <ref type="bibr" target="#b38">39</ref></s><s>Indeed, the reduction of IHL in our study was accompanied by the improvement of whole-body insulin sensitivity and adipose tissue insulin resistance.</s><s>As expected, at baseline and after the intervention we observed significant correlations of circulating FFA with IHL.</s><s>Strong associations were seen for saturated FFA including C14:0, C16:0 and C18:0 as well as for palmitoleic acid (C16:1n7) confirming previous observations. <ref type="bibr" target="#b39">40</ref></s><s>e decrease of these FFA therefore was associated with the reduction of liver fat.</s><s>This conclusion is supported by the correlated reduction of hepatic fat and the saturated stearic acid in both groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>21 Importantly, FFA were recently shown to directly induce hepatic glucose production in addition to their contribution to liver fat. <ref type="bibr" target="#b40">41,</ref><ref type="bibr">42</ref> </s><s>sma FFA and enzyme activity indices reflect mostly fatty acid metabolism in SAT since they are predominantly secreted from SAT. <ref type="bibr" target="#b30">31</ref> Reductions of fasting FFA point to improved insulin sensitivity in adipose tissue supported by the increased whole-body insulin sensitivity in AP and decreased HSL expression in PP group as well as the diminished adipose tissue insulin resistance index in the entire cohort.</s><s>Both, elongase activity index and DNL index were significantly decreased in AP and PP groups, the latter of which correlated with the IHL decrease.</s><s>The data also agree with the reductions of total fat mass, VAT, NVAT, and IHL.</s><s>Expression of genes involved in lipogenesis (defined as both the process of fatty acid synthesis and triglyceride synthesis) were decreased in SAT (ACC1 and SCD1 in AP group and PGC1A and PPARG in PP group).</s><s>As we did not use isotope tracers, we cannot distinguish exactly between changes in adipose tissue and liver but rather observe an overall decrease in lipogenesis and lipolysis as reflected by the reduction of FFA.</s></p><p><s>Recently, long term correlations of FFA and ∆5 and ∆6 desaturase activities with diabetes risk were published from a 19 year follow up of the Kuopio ischemic heart disease study including 2189 men. <ref type="bibr" target="#b31">32</ref></s><s>abetes risk was inversely related to linoleic acid and directly correlated with γ-linolenic acid as well as with ∆6 desaturase activity.</s><s>This mirrors the changes of FFA observed in response to the high-protein diets which showed a correlation of γ-linolenic acid with liver fat, while linoleic acid remained at a high level and ∆6 desaturase decreased.</s><s>A positive association of γ-linolenic acid with liver fat has been observed in plasma lipidomic studies of NAFLD and NASH in agreement with our data. <ref type="bibr" target="#b42">43</ref></s><s>This not only confirms the diabetes preventive effect of lowering γ-linolenic acid but also links it to the reduction of hepatic fat content which is closely related to diabetes risk. <ref type="bibr" target="#b31">32</ref></s><s>The high level of</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>22 linoleic acid is known to inhibit ChREBP and was shown to reduce liver fat in a human study. <ref type="bibr" target="#b43">44</ref></s><s>cent analyses linked prostanoid metabolites of arachidonic acid and ω-6 PUFAs to NAFLD and to its progression to NASH <ref type="bibr" target="#b44">45</ref> supporting the positive impact of the high-protein diets which decreased arachidonic acid.</s><s>The high-protein diets thus exert important parts of their activities through the changes of lipid and adipose tissue metabolism.</s></p><p><s>Since we essentially exchanged fat versus protein (carbohydrate intake was 40 E% before and during the study), the lower fat intake might have also contributed to diminished de novo lipogenesis in liver.</s></p><p><s>However, most studies report a positive association of carbohydrate intake with lipogenesis, <ref type="bibr" target="#b45">46</ref> while the role of fat appears to depend on the type of fat and extend of NAFLD. <ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b43">44</ref> </s><s>arkably, the improvement of IHL was not related to changes in body weight and fat mass, neither to VAT or NVAT content.</s><s>We observed no increase in whole-body REE and no change of fat oxidation rates in the fasting state as calculated from indirect calorimetry.</s><s>Expectedly, protein oxidation was highly induced in all participants.</s></p><p><s>As the AP diet induced much larger postprandial increases in BCAA and also methionine we expected a more favorable response to the PP diet than to AP. Levels of BCAA were not increased in the fasting state but showed large differences between the diets postprandially.</s><s>Therefore, their degradation must have been increased which may involve the liver, adipose tissue, and muscle. <ref type="bibr" target="#b10">11</ref></s><s>This may be reflected by changes of gene expression of the degrading pathway, <ref type="bibr" target="#b10">11</ref> but in adipose tissue the expression of BCAT and BCKDH did not change.</s><s>Still, the BCAA catabolism in human occurs mostly in muscle and liver, <ref type="bibr" target="#b46">47</ref> suggesting the activation of the BCAA degrading pathway in those tissues.</s></p><p><s>In contrast to our expectations, we found no evidence for an activation of the mTOR pathway in adipose tissue.</s><s>Activation of mTOR requires leucine which was higher in the AP group.</s><s>Nevertheless,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>23 phosphorylation of p70S6 kinase decreased significantly in the AP group suggesting decreased activation of the mTOR pathway in adipose tissue.</s><s>No activation was observed at gene expression level.</s><s>This may also explain the preferential loss of adipose since mTOR mediates trophic stimuli.</s><s>We did not determine a possible activation of the mTOR pathway in muscle.</s><s>Gran et al. showed a postprandial induction of the mTOR pathway in skeletal muscle after ingestion of protein rich meal <ref type="bibr" target="#b47">48</ref> which may be expected in our cohort since lean tissue mass increased.</s><s>However, the significant improvement of insulin sensitivity which we observed in hyperinsulinemic euglycemic clamps excludes a clinically relevant activation of the p70S6 kinase pathway in skeletal muscle. <ref type="bibr" target="#b7">8</ref></s><s>Therefore, the detrimental effects of BCAA or their α-ketoacid degradation products described in some settings do not apply to a high animal-protein intake in the presence of an isocaloric diet without restriction of energy intake. <ref type="bibr" target="#b13">14</ref></s><s>This is in line with other studies demonstrating metabolic improvements with high-protein diets <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b48">49</ref> and strongly argues against an important role of an activation of the mTOR pathway upon increased BCAA intake in humans.</s><s>Clearly, BCAA are related to insulin resistance but they do not seem to respond to changes in protein intake.</s></p><p><s>The extensive reduction of FGF21 with the high-protein diet was unexpected.</s><s>The reduction might reflect an improvement of hepatic ER-stress and improved mitochondrial function due to the reduction of liver fat.</s><s>Markers of ER-stress such as XBP-1 and IRE1 were shown to correlate highly with elevated levels of FGF21. <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b49">50</ref> </s><s>lthough we had no access to liver biopsy samples, it appears likely that the IHL reduction was accompanied by decrease of hepatic ER-stress and thus FGF21 release.</s><s>We did not observe changes in the expression of ER-stress markers in human adipose tissue, which is a primary target of FGF21 where it acts on FGFR1c and FGFR2c in combination with β-Klotho. <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b51">52</ref> R</s><s>stance to FGF21 has been proposed and represents a possible cause of elevated FGF21 in obesity</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head><p><s>ACCEPTED MANUSCRIPT 24 and T2D. <ref type="bibr" target="#b32">33</ref></s><s>However, expression of β-Klotho (KLB) was not altered and FGFR1 decreased in our study, which does not support changes of peripheral FGF21-sensititvity and is similar to data in mouse models. <ref type="bibr" target="#b50">51</ref></s><s>e reduction of FGF21 was accompanied by an improvement of markers of hepatic metabolism and of FFA.</s><s>Changes in lipid metabolic enzyme transcripts were highly associated with the changes in FGF21 signaling pathways which implies that FGF21 plays some role in the metabolic effects of high-protein diets or is highly co-regulated.</s><s>The decrease in FGF21 adds a novel aspect to the puzzle of FGF21.</s><s>Although application of FGF21 rapidly improves metabolism in all models of obese mice, <ref type="bibr" target="#b50">51</ref> increased levels of FGF21 are induced by obesity and associated with increased risks of metabolic and cardiovascular diseases. <ref type="bibr">16-18, 33, 50</ref></s><s>The reduction of IHL might therefore reduce FGF21 which is supported by the correlation of FGF21 with IHL and by the highly correlated gene expression network in adipose tissue.</s><s>FGF21 thus appears to regulate lipid biosynthetic pathways closely linked to the loss of IHL induced by the high-protein intake.</s><s>Since increased levels of FGF21 were invariably linked to unfavorable outcomes the decrease may be interpreted as a positive signal reflecting the metabolic improvement.</s></p><p><s>Nevertheless it is difficult to envision how a decrease of FGF21 should be instrumental in mediating the improvements of metabolism.</s><s>The increased protein intake therefore is likely to involve other gene regulatory pathways, such as the NO-arginine cycle which has a major impact on glucose and lipid metabolism. <ref type="bibr" target="#b52">53,</ref><ref type="bibr" target="#b53">54</ref> </s><s>ably, FGF21 was associated to higher carbohydrate and lower fat and protein consumption <ref type="bibr" target="#b54">55,</ref><ref type="bibr" target="#b55">56</ref> and thus might act as a nutrient sensor to regulate macronutrient intake.</s><s>It was shown that exogenous as well as fructose induced FGF21 suppresses sweet preference in a negative feedback loop. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b56">57</ref> </s><s>n the</s></p><formula xml:id="formula_2">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 25</formula><p><s>other hand, protein/amino acids restriction stimulates FGF21, <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13</ref> but decreased with high protein intake as shown in this study.</s><s>Collectively is could be assumed that FGF21 is tightly coupled with macronutrient intake and choice.</s></p><p><s>Longitudinal observations showed a strong association of keratin 18 decrease with improvement in liver histology in children and adults with NAFLD. <ref type="bibr" target="#b57">58</ref></s><s>The diminished keratin 18 levels indicated a beneficial role of high-protein diets on hepatic necroinflammation.</s><s>The absence of changes in the ELF score may reflect a low degree of fibrosis in our cohort.</s><s>Despite the extensive reduction of IHL, levels of aminotransferases showed only minor reductions by 10 -15% which may be explained by the low baseline levels and low AST/ALT ratio.</s><s>Blood levels of γ-GT declined in both groups with 24-30% suggesting a reduced oxidative challenge.</s></p><p><s>In conclusion, we demonstrated the effective reduction of IHL in patients with T2D and NAFLD consuming isocaloric high-protein diets.</s><s>Unexpectedly, both AP and PP groups showed this beneficial effect associated with decrease of hepatic markers, fasting FFA and FGF21 as well as increase of insulin sensitivity.</s><s>Moreover, molecular analysis of the signaling pathways in SAT revealed no activation of mTOR pathway upon the AP or PP diet.</s><s>Nevertheless, larger and longer dietary intervention studies are needed to show the durability of the responses and eventual adverse effects of the diets.</s><s>Moreover, the beneficial responses may be age related since our cohort was over 60 years old and age related effects may play a particular role in protein intake.</s></p><note type="other">Figure Legends</note></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>aim of the present study was to compare the effects of two isocaloric high-protein diets, containing either animal or plant protein on liver fat content in subjects with T2D accompanied by NAFLD.</s><s>To additionally explore possible mechanisms of liver fat alteration, lipogenic indices, inflammation markers, serum levels of FGF21 and activation of signaling pathways in adipose tissue and their association with liver fat reduction were assessed.</s><s>This randomized clinical trial with an open-label, parallel-arm study design was approved by the Ethics Committee of the University of Potsdam, conducted in accordance with the Declaration of Helsinki, and registered at www.clinicaltrials.gov</s><s>(NCT02402985).</s><s>All participants provided written informed consent before starting the study.</s><s>The study took place at the Department of Clinical Nutrition of the German Institute of Human Nutrition Potsdam-Rehbruecke (Nuthetal, Germany) from June 2013 to March 2015.</s><s>All authors had access to the study data and had reviewed and approved the final version of the manuscript.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Statistical significance was defined as P &lt; 0.05.</s><s>Data where examined for normality by the Shapiro-Wilk test.</s><s>Non-normally distributed variables were transformed with the natural logarithm and re-assessed for normality.</s><s>Comparisons between two groups were tested by Student's t test (paired and unpaired) or non-parametric tests (Wilcoxon and Mann-Whitney-U-Test). Multiple comparisons were analyzed by one-way or two-way ANOVA.</s><s>Depending on data distribution, Pearson's coefficient or Spearman's rank correlation coefficient was used for correlation analysis.</s><s>All statistical analyses were performed with SPSS 20.0 (Chicago, USA).</s><s>The network was calculated in R (version 3.1.2,</s><s>The R Project for Statistical Computing, Vienna, Austria) using RStudio (version 0.98.1091,</s><s>RStudio Inc.,</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>) while the M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 17 AP meal resulted in much larger increases in methionine and BCAA (Figure 3C-F), corresponding with the amino acid content of the different protein types.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>High-protein diet reduced IHL, VAT, SAT, and serum FGF21 in T2DM.</s><s>Boxplots and</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Relative reduction of IHL correlates with relative changes in metabolic parameters.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Differences in postprandial FAA levels after AP and PP meals.</s><s>Plasma levels of arginine</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. High-protein diet regulates gene expression in subcutaneous adipose tissue.</s><s>Changes in</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. High-protein diet does not induce activation of the mTOR pathway in SAT.</s><s>A: changes</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc><div><p><s>as mean±SEM.</s><s>AdipoIR (adipose tissue insulin resistance) = fasting insulin [µU/ml] x fasting total FFA [µg/ml].</s><s>NS, not significant (P&gt;.05).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>High-protein diet reduced IHL, VAT, SAT, and serum FGF21 in T2DM.</s><s>Boxplots and individual changes in intrahepatic lipid content (A) and serum FGF21 (C) after 6 weeks of intervention; B: changes in adipose tissue depots after 6 week of intervention.</s><s>15≤n AP ≤18, 17≤n PP ≤19, results are shown as mean±SEM (B).</s><s>*P&lt;.05, **P&lt;.01,</s><s>***P&lt;.001.</s><s>NS, not significant.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Figure 2 .Figure 3 .</head><label>23</label><figDesc><div><p><s>Figure 2. Relative reduction of IHL correlates with relative changes in metabolic parameters.Correlation between the relative change in IHL from week 0 to week 6 with the relative change in fasting plasma glucose (A), fasting serum insulin (B), whole-body insulin sensitivity (M-value) (C), fasting plasma stearic acid C18:0 (D), fasting plasma γ-linoleic acid C18:3n6 (E), and lipogenic index C16:0/C18:2n6 (F).</s><s>n AP =15, n PP =17.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Changes in anthropometric measurements, routine blood parameters and substrate oxidation.</head><label>1</label><figDesc></figDesc><table><row><cell>Parameter</cell><cell cols="2">Animal protein (AP), n = 18</cell><cell></cell><cell cols="2">Plant protein (PP), n = 19</cell><cell></cell><cell>AP versus PP</cell></row><row><cell></cell><cell>week 0</cell><cell>week 6</cell><cell>P AP</cell><cell>week 0</cell><cell>week 6</cell><cell>P PP</cell><cell>P APvsPP</cell></row><row><cell>BMI [kg/m 2 ]</cell><cell>31.0 ± 0.8</cell><cell>30.2 ± 0.7</cell><cell>0.003</cell><cell>29.4 ± 1.0</cell><cell>28.9± 1.0</cell><cell>0.001</cell><cell>NS</cell></row><row><cell>Waist [cm]</cell><cell>104.2 ± 2.6</cell><cell>102.2 ± 2.0</cell><cell>NS</cell><cell>100.7 ± 3.0</cell><cell>99.4 ± 2.9</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Hip [cm]</cell><cell>107.8 ± 1.8</cell><cell>106.3 ± 1.6</cell><cell>NS</cell><cell>105.3 ± 2.0</cell><cell>103.2 ± 1.9</cell><cell>0.034</cell><cell>NS</cell></row><row><cell>WHR</cell><cell>0.967 ± 0.018</cell><cell>0.962 ± 0.015</cell><cell>NS</cell><cell>0.957 ± 0.024</cell><cell>0.964 ± 0.025</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Fat mass [%]</cell><cell>35.26 ± 2.19</cell><cell>33.36 ± 1.94</cell><cell>0.023</cell><cell>34.95 ± 2.30</cell><cell>33.55 ± 2.20</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Fat-free mass [%]</cell><cell>64.74 ± 2.19</cell><cell>66.64 ± 1.94</cell><cell>0.023</cell><cell>65.05 ± 2.30</cell><cell>66.45 ± 2.20</cell><cell>NS</cell><cell>NS</cell></row><row><cell>AT femur [ml]</cell><cell cols="5">394.25 ± 17.51 372.15 ± 19.66 0.016 372.73 ± 26.18 348.05 ± 17.56</cell><cell>NS</cell><cell>NS</cell></row><row><cell>AST [U/l]</cell><cell>26.64 ± 1.85</cell><cell>22.36 ± 1.44</cell><cell>NS</cell><cell>23.88 ± 2.13</cell><cell>20.37 ± 1.23</cell><cell>0.020</cell><cell>NS</cell></row><row><cell>ALT [U/l]</cell><cell>30.44 ± 2.47</cell><cell>27.09 ± 1.93</cell><cell>NS</cell><cell>29.59 ± 2.97</cell><cell>26.52 ± 2.01</cell><cell>NS</cell><cell>NS</cell></row><row><cell>AST/ALT ratio</cell><cell>0.88 ± 0.06</cell><cell>0.84 ± 0.05</cell><cell>NS</cell><cell>0.80 ± 0.04</cell><cell>0.80 ± 0.04</cell><cell>NS</cell><cell>NS</cell></row><row><cell>γ-GT [U/l]</cell><cell>44.31 ± 6.82</cell><cell>31.51 ± 4.23</cell><cell>0.017</cell><cell>41.76 ± 5.25</cell><cell>31.94 ± 3.61</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Keratin 18 [U/l]</cell><cell>184.9 ± 28.9</cell><cell>159.7 ± 20.8</cell><cell>NS</cell><cell>197.4 ± 26.2</cell><cell>151.2 ± 13.9</cell><cell>0.021</cell><cell>NS</cell></row><row><cell>ELF score</cell><cell>9.19 ± 0.15</cell><cell>9.01 ± 0.16</cell><cell>NS</cell><cell>9.02 ± 0.17</cell><cell>9.11 ± 0.15</cell><cell>NS</cell><cell>NS</cell></row><row><cell>PIIINP [ng/ml]</cell><cell>7.73 ± 0.53</cell><cell>7.05 ± 0.26</cell><cell>NS</cell><cell>8.07 ± 0.49</cell><cell>7.98 ± 0.41</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Adiponectin [ng/ml]</cell><cell cols="2">4063.6 ± 836.1 3661.4 ± 727.0</cell><cell>NS</cell><cell cols="3">4239.1 ± 395.6 3653.5 ± 317.1 0.003</cell><cell>NS</cell></row><row><cell>AdipoIR</cell><cell>11.99 ± 2.32</cell><cell>8.61 ±1.34</cell><cell>0.019</cell><cell>10.24 ± 1.71</cell><cell>9.87 ± 2.20</cell><cell>0.026</cell><cell>NS</cell></row><row><cell>Substrate oxidation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Resting energy expenditure [kcal/day] 1682.1 ± 68.8</cell><cell>1628.3 ± 67.2</cell><cell>NS</cell><cell>1604.6 ± 61.5</cell><cell>1594.4 ± 75.6</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Respiratory quotient</cell><cell>0.86 ± 0.02</cell><cell>0.84 ± 0.02</cell><cell>NS</cell><cell>0.84 ± 0.02</cell><cell>0.85 ± 0.02</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Carbohydrate oxidation [g/min]</cell><cell>0.158 ± 0.017</cell><cell>0.144 ± 0.023</cell><cell>NS</cell><cell>0.139 ± 0.017</cell><cell>0.138 ± 0.014</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Fat oxidation [g/min]</cell><cell>0.060 ± 0.008</cell><cell>0.064 ± 0.008</cell><cell>NS</cell><cell>0.066 ± 0.007</cell><cell>0.067 ± 0.008</cell><cell>NS</cell><cell>NS</cell></row><row><cell>24-h urinary nitrogen [g/day]</cell><cell cols="6">11.477 ± 0.876 17.240 ± 1.403 &lt;0.001 11.245 ± 1.012 16.027 ± 1.337 0.005</cell><cell>NS</cell></row><row><cell>Protein oxidation [g/min]</cell><cell>0.050 ± 0.004</cell><cell cols="3">0.075 ± 0.006 &lt;0.001 0.049 ± 0.004</cell><cell cols="2">0.070 ± 0.006 0.005</cell><cell>NS</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 . Changes in plasma free fatty acids and enzyme activity indices in the fasting state.</head><label>2</label><figDesc></figDesc><table><row><cell>Free fatty acid</cell><cell></cell><cell cols="3">Animal Protein Diet (AP), n = 18</cell><cell cols="3">Plant Protein Diet (PP), n = 19</cell><cell>AP versus PP</cell></row><row><cell>[µg/ml]</cell><cell></cell><cell>week 0</cell><cell>week 6</cell><cell>P AP</cell><cell>week 0</cell><cell>week 6</cell><cell>P PP</cell><cell>P APvsPP</cell></row><row><cell>Myristic acid</cell><cell>C14:0</cell><cell>27.04 ± 1.56</cell><cell>24.46 ± 1.69</cell><cell>0.045</cell><cell>27.28 ± 1.95</cell><cell>23.47 ± 1.87</cell><cell>0.013</cell><cell>NS</cell></row><row><cell>Pentadecylic acid</cell><cell>C15:0</cell><cell>4.51 ± 0.26</cell><cell>4.57 ± 0.25</cell><cell>NS</cell><cell>4.25 ± 0.26</cell><cell>4.05 ± 0.24</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Palmitic acid</cell><cell>C16:0</cell><cell cols="6">216.84 ± 13.33 189.32 ± 13.35 0.005 217.56 ± 14.00 183.58 ± 11.51 0.007</cell><cell>NS</cell></row><row><cell>Palmitoleic acid</cell><cell>C16:1n7</cell><cell>45.92 ± 3.56</cell><cell>41.12 ± 3.80</cell><cell>0.005</cell><cell>47.35 ± 3.98</cell><cell>40.38 ± 3.57</cell><cell>0.030</cell><cell>NS</cell></row><row><cell>Margaric acid</cell><cell>C17:0</cell><cell>4.01 ± 0.21</cell><cell>3.90 ± 0.21</cell><cell>NS</cell><cell>3.78 ± 0.18</cell><cell>3.68 ± 0.23</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Stearic acid</cell><cell>C18:0</cell><cell>45.77 ± 2.10</cell><cell>36.63 ± 2.13</cell><cell>0.000</cell><cell>44.82 ± 2.09</cell><cell>35.61 ± 1.85</cell><cell>0.000</cell><cell>NS</cell></row><row><cell>Oleic acid</cell><cell>C18:1n9</cell><cell cols="6">297.08 ± 15.99 263.83 ± 14.32 0.012 302.99 ± 18.94 249.24 ± 15.48 0.002</cell><cell>NS</cell></row><row><cell>Vaccenic acid</cell><cell>C18:1n7</cell><cell>30.48 ± 1.73</cell><cell>28.11 ± 1.52</cell><cell>0.018</cell><cell>30.35 ± 2.02</cell><cell>26.27 ± 1.58</cell><cell>0.025</cell><cell>NS</cell></row><row><cell>Linoleic acid</cell><cell>C18:2n6</cell><cell cols="2">277.69 ± 11.41 270.79 ± 8.69</cell><cell>NS</cell><cell cols="2">282.38 ± 8.61 278.31 ± 10.98</cell><cell>NS</cell><cell>NS</cell></row><row><cell>γ-Linolenic acid</cell><cell>C18:3n6</cell><cell>13.60 ± 0.77</cell><cell>11.92 ± 0.74</cell><cell>0.005</cell><cell>14.13 ± 0.81</cell><cell>13.00 ± 1.03</cell><cell>NS</cell><cell>NS</cell></row><row><cell>α-Linolenic acid</cell><cell>C18:3n3</cell><cell>16.42 ± 0.84</cell><cell>22.28 ± 1.40</cell><cell>0.001</cell><cell>17.40 ± 0.90</cell><cell>19.03 ± 1.71</cell><cell>NS</cell><cell>0.024</cell></row><row><cell>Dihomo-γ-linolenic acid</cell><cell>C20:3n6</cell><cell>12.68 ± 0.58</cell><cell>11.75 ± 0.64</cell><cell>NS</cell><cell>12.51 ± 0.75</cell><cell>12.24 ± 0.72</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Arachidonic acid</cell><cell>C20:4n6</cell><cell>63.54 ± 2.76</cell><cell>57.70 ± 3.00</cell><cell>0.006</cell><cell>65.09 ± 4.08</cell><cell>51.19 ± 3.55</cell><cell>0.001</cell><cell>NS</cell></row><row><cell>Eicosapentaenoic acid</cell><cell>C20:5n3</cell><cell>19.82 ± 1.27</cell><cell>19.18 ± 1.30</cell><cell>NS</cell><cell>20.22 ± 1.70</cell><cell>16.45 ± 1.18</cell><cell>0.019</cell><cell>NS</cell></row><row><cell>Lignoceric acid</cell><cell>C24:0</cell><cell>2.64 ± 0.24</cell><cell>2.39 ± 0.19</cell><cell>0.046</cell><cell>2.82 ± 0.20</cell><cell>2.55 ± 0.17</cell><cell>0.036</cell><cell>NS</cell></row><row><cell>Nervonic acid</cell><cell>C24:1n9</cell><cell>2.61 ± 0.15</cell><cell>2.62 ± 0.14</cell><cell>NS</cell><cell>2.60 ± 0.14</cell><cell>2.53 ± 0.10</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Docosapentaenoic acid n6</cell><cell>C22:5n6</cell><cell>16.35 ± 1.28</cell><cell>11.23 ± 0.64</cell><cell>0.000</cell><cell>17.97 ± 1.44</cell><cell>11.63 ± 0.75</cell><cell>0.000</cell><cell>NS</cell></row><row><cell>Docosapentaenoic acid n3</cell><cell>C22:5n3</cell><cell>9.08 ± 0.27</cell><cell>8.31 ± 0.30</cell><cell>0.023</cell><cell>8.99 ± 0.27</cell><cell>8.05 ± 0.38</cell><cell>0.019</cell><cell>NS</cell></row><row><cell>Docosahexaenoic acid</cell><cell>C22:6n3</cell><cell>22.56 ± 0.60</cell><cell>20.89 ± 1.09</cell><cell>NS</cell><cell>21.66 ± 1.74</cell><cell>17.06 ± 0.99</cell><cell>0.003</cell><cell>NS</cell></row><row><cell>Enzyme activity index</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SCD1 activity index</cell><cell>C16:1 / C16:0</cell><cell>0.21 ± 0.01</cell><cell>0.21 ± 0.01</cell><cell>NS</cell><cell>0.22 ± 0.01</cell><cell>0.22 ± 0.00</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Elongase activity index</cell><cell>C18:0 / C16:0</cell><cell>0.22 ± 0.01</cell><cell>0.20 ± 0.01</cell><cell>0.014</cell><cell>0.21 ± 0.01</cell><cell>0.20 ± 0.00</cell><cell>0.027</cell><cell>NS</cell></row><row><cell>Lipogenic index</cell><cell>C16:0 / C18:2n6</cell><cell>0.78 ± 0.04</cell><cell>0.70 ± 0.04</cell><cell>0.003</cell><cell>0.77 ± 0.05</cell><cell>0.67 ± 0.04</cell><cell>0.006</cell><cell>NS</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We acknowledge all study participants for their cooperation.</s><s>We gratefully thank Katrin Sprengel, Andrea Borchert, Melanie Hannemann, Alexandra Jochen, Dominique Zschau, Stephanie Peglow and Katja Treu (Department of Clinical Nutrition, German Institute of Human Nutrition, Nuthetal,</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>Author names in bold designate shared co-first authors.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Nonalcoholic fatty liver disease: a systematic review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Rinella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">313</biblScope>
			<biblScope unit="page" from="2263" to="2273" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications</title>
		<author>
			<persName><forename type="first">G</forename><surname>Targher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Byrne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="483" to="495" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Shulman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="713" to="723" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Tsatsos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Towle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="12019" to="12027" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sarraf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wright</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Goldstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="3441" to="3446" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome</title>
		<author>
			<persName><forename type="first">S</forename><surname>Menon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Dibble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Talbott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="771" to="785" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrientand obesity-induced insulin resistance</title>
		<author>
			<persName><forename type="first">F</forename><surname>Tremblay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hee</forename><surname>Um</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="14056" to="14061" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">High dietary protein intake, reducing or eliciting insulin resistance?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rietman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tome</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="973" to="979" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The metabolic response of subjects with type 2 diabetes to a high-protein, weight-maintenance diet</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Q</forename><surname>Nuttall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Gannon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saeed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="3577" to="3583" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Branched-chain amino acids in metabolic signalling and insulin resistance</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Adams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="723" to="736" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">FGF21 is an endocrine signal of protein restriction</title>
		<author>
			<persName><forename type="first">T</forename><surname>Laeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Henagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Albarado</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="3913" to="3922" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gallinetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Harputlugil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mitchell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">449</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Interplay between lipids and branched-chain amino acids in development of insulin resistance</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Newgard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="606" to="614" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Mccarty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Hypotheses</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="365" to="371" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China</title>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Fang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hepatol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="557" to="563" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dushay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Chui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Gopalakrishnan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="456" to="463" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="380" to="390" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Fructose ingestion acutely stimulates circulating FGF21 levels in humans</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Dushay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Toschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Mitten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Metab</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="51" to="57" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver</title>
		<author>
			<persName><forename type="first">S</forename><surname>Von Holstein-Rathlou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Bondurant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Peltekian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bobbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Groth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="page" from="E126" to="130" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans</title>
		<author>
			<persName><forename type="first">F</forename><surname>Theytaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Noguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Egli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1008" to="1016" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bortolotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Maiolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Corazza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="494" to="498" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">High protein intake reduces intrahepatocellular lipid deposition in humans</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bortolotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kreis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Debard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1002" to="1010" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Increasing protein intake modulates lipid metabolism in healthy young men and women consuming a high-fat hypercaloric diet</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rietman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Blokker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="1174" to="1180" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Machann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Stefan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">257</biblScope>
			<biblScope unit="page" from="353" to="363" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Calculation of substrate oxidation rates in vivo from gaseous exchange</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Frayn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol Respir Environ Exerc Physiol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="628" to="634" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Szczepaniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nurenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Leonard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="E462" to="468" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">O</forename><surname>Ku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Strnad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Zhong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1639" to="1649" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values</title>
		<author>
			<persName><forename type="first">R</forename><surname>Lichtinghagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pietsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bantel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hepatol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="236" to="242" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Splanchnic lipolysis in human obesity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="1582" to="1588" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Serum n-6 polyunsaturated fatty acids, Delta5-and Delta6-desaturase activities, and risk of incident type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Voutilainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Tuomainen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gallego-Escuredo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gomez-Ambrosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Catalan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Obes</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="121" to="129" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Brozinick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="790" to="797" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Hepatic Steatosis as a Marker of Metabolic Dysfunction</title>
		<author>
			<persName><forename type="first">E</forename><surname>Fabbrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Magkos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutrients</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="4995" to="5019" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Bradbury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Gastrointest Liver Physiol</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="page" from="G194" to="198" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bugianesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gastaldelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vanni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="634" to="642" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content</title>
		<author>
			<persName><forename type="first">E</forename><surname>Fabbrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Deivanayagam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obesity (Silver Spring)</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="25" to="29" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease</title>
		<author>
			<persName><forename type="first">E</forename><surname>Fabbrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Magkos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="424" to="431" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver</title>
		<author>
			<persName><forename type="first">P</forename><surname>Iozzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lautamaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Geisler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1149" to="1156" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Vatner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Majumdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kumashiro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="1143" to="1148" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Camporez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kursawe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="745" to="758" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The plasma lipidomic signature of nonalcoholic steatohepatitis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Puri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Wiest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Cheung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1827" to="1838" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bjermo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Iggman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kullberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="1003" to="1012" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Loomba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Quehenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Armando</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="185" to="192" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sevastianova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kotronen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="727" to="734" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">A molecular model of human branched-chain amino acid metabolism</title>
		<author>
			<persName><forename type="first">A</forename><surname>Suryawan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Hawes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Harris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="72" to="81" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Muscle p70S6K phosphorylation in response to soy and dairy rich meals in middle aged men with metabolic syndrome: a randomised crossover trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Gran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bonham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr Metab (Lond)</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">46</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Feasibility and efficacy of an isocaloric high-protein vs. standard diet on insulin requirement, body weight and metabolic parameters in patients with type 2 diabetes on insulin therapy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Luger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Holstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schindler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Clin Endocrinol Diabetes</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="286" to="294" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Fibroblast growth factor 21 is regulated by the IRE1alpha-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">C</forename><surname>Fang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="29751" to="29765" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stanislaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="69" to="80" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kharitonenkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Dunbar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Bina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Jobgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Fu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr Biochem</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="571" to="588" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice</title>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="E1234" to="1244" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Novel locus including FGF21 is associated with dietary macronutrient intake</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Workalemahu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Paynter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1895" to="1902" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Ngwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Van Rooij</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1395" to="1402" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">FGF21 Regulates Sweet and Alcohol Preference</title>
		<author>
			<persName><forename type="first">S</forename><surname>Talukdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="344" to="349" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease</title>
		<author>
			<persName><forename type="first">R</forename><surname>Vuppalanchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Deppe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="2121" to="2130" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
